Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome.
Saved in:
| Title: | Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome. |
|---|---|
| Authors: | Schworer EK; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA., Handen BL; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Petersen M; Department of Family Medicine and Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA., O'Bryant S; Department of Family Medicine and Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA., Peven JC; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Tudorascu DL; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Lee L; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Krinsky-McHale SJ; New York State Institute for Basic Research in Developmental Disabilities Staten Island New York USA., Hom CL; Department of Psychiatry and Human Behavior University of California Irvine California USA., Clare ICH; Department of Psychiatry University of Cambridge Cambridge UK., Christian BT; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA., Schupf N; Taub Institute for Research on Alzheimer's Disease and the Aging Brain Sergievsky Center and Department of Neurology Vagelos College of Physicians and Surgeons Columbia University New York New York USA., Lee JH; Taub Institute for Research on Alzheimer's Disease and the Aging Brain Sergievsky Center and Department of Neurology Vagelos College of Physicians and Surgeons Columbia University New York New York USA., Head E; Department of Pathology & Laboratory Medicine University of California Irvine School of Medicine Irvine California USA., Mapstone M; Department of Neurology University of California Irvine School of Medicine Irvine California USA., Lott I; Department of Neurology University of California Irvine School of Medicine Irvine California USA., Ances BM; Department of Neurology Washington University at St. Louis St. Louis Missouri USA., Zaman S; Department of Psychiatry University of Cambridge Cambridge UK., Brickman AM; Taub Institute for Research on Alzheimer's Disease and the Aging Brain Sergievsky Center and Department of Neurology Vagelos College of Physicians and Surgeons Columbia University New York New York USA., Lai F; Department of Neurology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA., Rosas HD; Department of Neurology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA.; Center for Neuro-imaging of Aging and Neurodegenerative Diseases Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA., Hartley SL; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA.; School of Human Ecology University of Wisconsin-Madison Madison Wisconsin USA. |
| Corporate Authors: | Alzheimer Biomarker Consortium‐Down Syndrome |
| Source: | Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2024 Apr 14; Vol. 16 (2), pp. e12582. Date of Electronic Publication: 2024 Apr 14 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2352-8729 |
|---|---|
| DOI: | 10.1002/dad2.12582 |
